Molecule Structure

Scientific Name

Tocainide

Description of the Drug

Tocainide is an orally active class 1b antiarrhythmic agent that interferes with cardiac sodium channels and typically used to treat ventricular arrhythmias.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB01056

Brand Name(s)

Not Available

Company Owner(s)

Astrazeneca Pharmaceuticals Lp

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Sodium channel alpha subunit PROTEIN FAMILY BLOCKER CHEMBL2331043

Unichem Links

SureChEMBL SCHEMBL15761
PharmGKB PA451706
Human Metabolome Database HMDB0015189
WDI TOCAINIDE
DrugBank DB01056
PubChem: Thomson Pharma 14797358
PubChem 38945
Mcule MCULE-9641637435
LINCS LSM-1909
Nikkaji J16.873D
EPA CompTox Dashboard DTXSID9040766
DrugCentral 2686
ChemicalBook CB8210193
Guide to Pharmacology 7309
GSRS d3a5d9a4-11d2-425b-9474-0b58f5147309
rxnorm TOCAINIDE
KEGG Ligand C07142
ChEBI 9611
NIH Clinical Collection SAM001246759